Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation

FASEB Journal

Volumn 25, Issue 1, 2011, Pages 382-388

  Chen, Ping ^a   Véricel, Evelyne ^a   Lagarde, Michel ^a   Guichardant, Michel ^a  

^a NONE

Author keywords

15 Lipoxygenase; Docosahexaenoic acid; Docosatrienes; Thromboxane receptor

Indexed keywords

10,17 DIHYDROXY DOCOSA HEXAENOIC ACID; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5,12 DIHYDROXY EICOSATETRAENOATE; 7,14 DIHYDROXY DOCOSA HEXAENOIC ACID; 8,15 DIHYDROXY EICOSATETRAENOATE; ANTICOAGULANT AGENT; ARACHIDONIC ACID; COLLAGEN; POLYUNSATURATED FATTY ACID; POXYTRIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ARACHIDONIC ACID; BLOOD PLATELETS; COLLAGEN; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; DICARBOXYLIC ACIDS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; ISOMERISM; OXYGEN; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, THROMBOXANE; THROMBOXANES;

GLYCINE MAX;

EID: 79251589025     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-161836     Document Type: Article

References (44)

1. Torrejon, C., Jung, U. J., and Deckelbaum, R. J. (2007) n-3 fatty acids and cardiovascular disease: actions and molecular mechanisms. Prostaglandins Leukot. Essent Fatty Acids 77, 319-326
2. Volcik, K. A., Nettleton, J. A., Ballantyne, C. M., and Boerwinkle, E. (2008) Peroxisome proliferator-activated receptor α genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study. Am. J. Clin. Nutr. 87, 1926-1931
3. Elvevoll, E. O., Eilertsen, K. E., Brox, J., Dragnes, B. T., Falkenberg, P., Olsen, J. O., Kirkhus, B., Lamglait, A., and Osterud, B. (2008) Seafood diets: hypolipidemic and anti-atherogenic effects of taurine and n-3 fatty acids. Atherosclerosis 200, 396-402
4. Leaf, A., Kang, J. X., and Xiao, Y. F. (2008) Fish oil fatty acids as cardiovascular drugs. Curr. Vasc. Pharmacol. 6, 1-12
5. Deckelbaum, R.J., Leaf, A., Mozaffarian, D., Jacobson, T.A., Harris, W. S., and Akabas, S. R. (2008) Conclusions and recommendations from the symposium, Beyond Cholesterol: Prevention and Treatment of Coronary Heart Disease with n-3 Fatty Acids. Am. J. Clin. Nutr. 87, 2010S-2012S
6. McCann, K. (2007) Nutrition and rheumatoid arthritis. Explore 3, 616-618
7. Galarraga, B., Ho, M., Youssef, H. M., Hill, A., McMahon, H., Hall, C., Ogston, S., Nuki, G., and Belch, J. J. (2008) Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology 47, 665-669
8. Galgani, J. E., Uauy, R. D., Aguirre, C. A., and Díaz, E. O. (2008) Effect of the dietary fat quality on insulin sensitivity. Br. J. Nutr. 8, 1-9
9. Merzouk, S. A., Saker, M., Reguig, K. B., Soulimane, N., Merzouk, H., Guermouche, B., Berrouiguet, A. Y., Hichami, A., Narce, M., and Khan, N. A. (2008) N-3 polyunsaturated fatty acids modulate in-vitro T cell function in type I diabetic patients. Lipids 43, 485-497
10. Mickelborough, T. D. (2005) Dietary omega 3 polyunsaturated fatty acid supplementation and airway hyperresponsiveness in asthma. J. Asthma 427, 305-314
11. McGahon, B. M., Martin, D. S., Horrobin, D. F., and Lynch, M. A. (1999) Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 94, 305-314
12. Gordon, W. C., and Bazan, N. G. (1990) Docosahexaenoic acid utilization during rod photoreceptor cell renewal. Neuroscience 10, 2190-2202
13. Mirnikjoo, B., Brown, S. E., Kim, H. F., Marangell, L. B., Sweatt, J. D., and Weeber, E. J. (2001) Protein kinase inhibition by omega-3 fatty acids. J. Biol. Chem. 276, 10888-10896
14. Kim, H. Y., Akbar, M., Lau, A., and Edsall, L. (2000) Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3): role of phosphatidylserine in antiaptotic effect. J. Biol. Chem. 275, 35215-35223
15. Lauritzen, I., Blondeau, N., Heurteaux, C., Widmann, C., Romey, G., and Lazdunski, M. (2000) Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 19, 1784-1793 (Pubitemid 30204390)
16. Rodriguez de Turco, E. B., Belayev, L., Liu, Y., Busto, R., Parkins, N., Bazan, N. G., and Ginsberg, M. D. (2002) Systemic fatty acid responses to transient focal cerebral ischemia: influence of neuroprotectant therapy with human albumin. J. Neurochem. 83, 515-524
17. Stark, K. D., and Holub, B. J. (2004) Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am. J. Clin. Nutr. 79, 765-773
18. Guillot, N., Caillet, E., Laville, M., Calzada, C., Lagarde, M., and Véricel, E. (2009) Increasing intakes of the long-chain w-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J. 23, 2909-2916
19. 14C] docosahexaenoic acid by human platelets. J. Biol. Chem. 258, 9339-9343
20. Kim, H. Y., Karanian, J. W., and Salem, N., Jr. (1990) Formation of 15-lipoxygenase product from docosahexaenoic acid (22: 6w3) by human platelets. Prostaglandins 40, 539-549
21. Miller, C., Yamaguchi, R. Y., and Ziboh, V. A. (1989) Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids. Lipids 24, 998-1003
22. Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., and Moussignac, R. L. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by treatment that counter proinflammation. J. Exp. Med. 196, 1025-1037
23. Hong, S., Gronert, K., Devchand, P. R., Moussignac, R. L., and Serhan, C. N. (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells: autacoids in anti-inflammation. J. Biol. Chem. 278, 14677-14687
24. Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., and Bazan, N. G. (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 101, 8491-8496
25. Bazan, N. G. (2005) Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 15, 159-166
26. Bazan, N. G. (2005) Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32, 89-103
27. Serhan, C. N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., Yang, R., Colgan, S. P., and Petasis, N. A. (2006) Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176, 1848-1859
28. González-Périz, A., Planagumà, A., Gronert, K., Miquel, R., López-Parra, M., Titos, E., Horrillo, R., Ferré, N., Deulofeu, R., Arroyo, V., Rodés, J., and Clària, J. (2006) Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 20, 2537-2539
29. Serhan, C. N., and Chiang, N. (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 153, S200-S215
30. Bazan, N. G. (2008) Neurotrophins induce neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis of the anti-inflammatory and anti-apoptotic neuroprotectin D1. Adv. Exp. Med. Biol. 613, 39-44
31. Butovich, I. A. (2006) A one-step method of 10,17-dihydro(pero) xydocosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic acid synthesis by soybean lipoxygenase. J. Lipid Res. 47, 854-863
32. Butovich, I. A., Lukyanova, S. M., and Bachmann, C. (2006) Dihydroxydocosahexaenoic acids of the neuroprotectin D family: synthesis, structure, and inhibition of human 5-lipoxygenase. J. Lipid Res. 47, 2462-2474
33. Chen, P., Fenet, B., Michaud, S., Tomczyk, N., Véricel, E., Lagarde, M., and Guichardant, M. (2009) Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett. 583, 3478-3484
34. Dangi, B., Obeng, M., Nauroth, J. M., Teymourlouei, M., Needham, M., Raman, K., and Arterburn, L. M. (2009) Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins from docosapentaenoic acid (DPAn-6). J. Biol. Chem. 284, 14744-14759
35. Croset, M., and Lagarde, M. (1983) Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem. Biophys. Res. Commun. 112, 878-883
36. Croset, M., Sala, A., Folco, G., and Lagarde, M. (1988) Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle: 14-hydroxy from 22:6n-3 is more potent than 12-HETE. Biochem. Pharmacol. 37, 1275-1280
37. Dona, M., Fredman, G., Schwab, J. M., Chiang, N., Arita, M., Goodarzi, A., Cheng, G., von Andrian, U. H., and Serhan, C. N. (2008) Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112, 848-855
38. Borgeat, P., Fruteau de Laclos, B., Picard, S., Drapeau, J., Vallerand, P., and Corey, E. J. (1982) Studies on the mechanism of formation of the 5S, 12S-dihydroxy-6,8,10,14(E,Z,E,Z)-icosatetraenoic acid in leukocytes. Prostaglandins 23, 713-724
39. Lagarde, M., Bryon, P. A., Guichardant, M., and Dechavanne, M. (1980) A simple and efficient method for platelet isolation from their plasma. Thromb. Res. 17, 581-588 (Pubitemid 10129052)
40. Born, G. V. (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927-992
41. Boukhchache, D., and Lagarde, M. (1982) Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim. Biophys. Acta 713, 386-392
42. Marquis, N. R., Vigdahl, R. L., and Tavormina, P. A. (1969) Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1. Biochem. Biophys. Res. Commun. 36, 965-972
43. Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, P. F., Oh, S. F., Spite, M. (2009) Maresins: novel macrophage mediators with potent anti-inflammatory and proresolving actions. J. Exp. Med. 206, 15-23
44. Lagarde, M., Boutillon, M. M., Guichardant, M., Lellouche, J. P., Beaucourt, J. P., Vanhove, A., and Grée, R. (1989) Further studies on the anti-thromboxane A2 activity of monohydroxylated fatty acids. Biochem. Pharmacol. 38, 1863-1864